dr. reddy's labs glp-1 receptor agonist weight management diabetes treatments Launches Obeda® as India's First Oral Semaglutide Biosimilar for Type 2 GLP-1 Receptor Agonists as Treatments
Pay in 4 interest-free payments of $5.33 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6























